Table 3.
Effect of LI12542F6 supplementation on 1-RM strength and handgrip strength
Parameters | Evaluations | Placebo (n = 20) | LI12542F6 (n = 20) |
---|---|---|---|
1-RM Bench press (kg) | Baseline | 44.45 ± 7.65 | 42.90 ± 8.39 |
Day 14 | 44.60 ± 8.57 | 49.40 ± 11.01*# | |
Day 28 | 46.10 ± 9.41 | 66.40 ± 9.29*# | |
Day 56 | 49.40 ± 9.54* | 70.50 ± 9.30*# | |
Change from baseline | 4.95 ± 2.52 | 27.60 ± 11.08# | |
1-RM Leg press (kg) | Baseline | 58.40 ± 9.17 | 61.45 ± 13.29 |
Day 14 | 59.55 ± 10.59 | 69.95 ± 13.91*# | |
Day 28 | 60.25 ± 11.40 | 80.80 ± 13.72*# | |
Day 56 | 64.10 ± 10.65* | 90.90 ± 11.91*# | |
Change from baseline | 5.70 ± 4.21 | 29.45 ± 8.29# | |
Handgrip strength (kg) | Baseline | 31.50 ± 4.01 | 32.50 ± 3.44 |
Day 14 | 35.50 ± 3.59* | 37.75 ± 3.43*# | |
Day 28 | 37.75 ± 4.44* | 41.10 ± 3.24*# | |
Day 56 | 42.10 ± 4.27* | 46.10 ± 3.24*# | |
Change from baseline | 10.60 ± 3.38 | 13.60 ± 2.46# |
Data present the mean ± SD.
indicates significance (P < 0.05) in intragroup comparison (vs. baseline) analyzed using student t-test;
indicates significance (P < 0.05) in between-the-groups comparison (vs. placebo) analyzed using ANCOVA model with treatment as fixed effects and baseline as a covariate.